4//SEC Filing
Happel David 4
Accession 0001104659-24-040517
CIK 0001400118other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 4:08 PM ET
Size
5.1 KB
Accession
0001104659-24-040517
Insider Transaction Report
Form 4
Happel David
DirectorPresident & CEO
Transactions
- Purchase
Series A Common Stock
2024-03-26$5.27/sh+12,100$63,731→ 639,200 total
Footnotes (1)
- [F1]Reflects the weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.24 per share to $5.2999 per share. The Reporting Person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Documents
Issuer
Sagimet Biosciences Inc.
CIK 0001400118
Entity typeother
Related Parties
1- filerCIK 0001623567
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 4:08 PM ET
- Size
- 5.1 KB